Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Axios
Axios
Health
Bob Herman

Gilead taps Roche exec Daniel O'Day as new CEO

Gilead is known for making hepatitis C and HIV medicines. Photo: Igor Golovniov/SOPA Images/LightRocket via Getty Images

Gilead Sciences has named Daniel O'Day, the chief of Roche's pharmaceuticals unit, as its new CEO, effective March 1.

Why it matters: Gilead is one of the largest and most profitable drug manufacturers on the planet, known for its hepatitis C and HIV medicines. O'Day will lead a company that has had falling sales of its hepatitis drugs and is investing more in new, expensive gene therapies.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.